|
|
| |
| Extra Fat May Quietly Feed Alzheimer’s |
| Your waistline may talk to your brain. Researchers at Houston Methodist just traced one of the messages. The team, led by Stephen Wong and Li Yang, looked at a family of fat molecules called phosphatidylethanolamines — think of them as bricks in the walls of your cells. Carry extra body fat, and these molecules climb. |
| Let me explain what happens next. The body packs those fats into tiny bubbles and ships them through the blood. Some reach the brain. Once there, they muddy the signals between brain cells, dull the brain’s own cleanup and defense crew, and let amyloid — the sticky gunk tied to Alzheimer’s — pile up. |
| |
When the team corrected the fat imbalance in their lab models, memory improved and the damage eased. The fat was not just sitting there. It was helping drive the fire. |
|
| Now, a fair caution. This work was done in Alzheimer’s models, not in people, so it is early days. I could be wrong about how fast it reaches the clinic. But it lines up with a theme you have seen here before: what is hard on your metabolism is hard on your brain. |
| You cannot control every risk for Alzheimer’s. This one you can nudge. I urge you to treat a trimmer waistline as brain care, not just heart care — a few steady pounds off is a quiet gift to your neurons. |
| Molecular Neurodegeneration · Houston Methodist · 2026 |
|
|
|
|
| |
| Give Your Caffeine A Cutoff Time |
| Coffee is good for your brain. Studies tie two or three cups a day to slower memory decline. So I am not asking you to quit. I am asking you to watch the clock. |
| The reason is in the chemistry. Caffeine works by blocking adenosine — the chemical that builds up all day and makes you sleepy. It is a fast worker but a slow leaver. Half of your afternoon cup can still be in your body six hours later. That leftover caffeine trims your deep sleep, the heavy, slow stage when your brain runs its nightly cleanup and clears the waste tied to Alzheimer’s. |
| So the fix is not less coffee. It is earlier coffee. |
| The Protocol |
| When |
| Last caffeine by about 2 p.m. — roughly 8 to 10 hours before bed. |
| Duration |
| Give it two weeks. Deep sleep shifts slowly. |
| Rules |
| Count the hidden sources — tea, cola, chocolate, pre-workout, even “decaf” has a little. Ease off over a few days, not all at once, so you dodge the headache. Keep your morning cup; that one is doing you good. |
| |
| Watch for one sign it is working: falling asleep faster and waking less at night. That is the deep sleep coming back. I urge you to give it two weeks and see. |
|
|
|
|
|
|
|
| A Blood Test That Sees Trouble Coming |
| Doctors are getting an early-warning tool. At this year’s Alzheimer’s Association International Conference, researchers followed about 2,700 healthy older adults. The ones with the highest levels of p-tau217 — a protein in the blood that tracks Alzheimer’s changes in the brain — had roughly a 78% chance of memory trouble within 10 years. A simple blood draw, a decade of warning. It is not a home kit, and a high reading is a risk, not a verdict. But it buys you and your doctor time to act. |
| Alzheimer’s Association International Conference · 2026 |
|
|
| Sit Up Straight, Decide Better |
| Your posture may sway your mind. In a new study from McGill University, people who sat upright reported a brighter mood and made bolder, more successful choices in a risk game than people who slouched. It is a small study, and posture is no cure. Still, it costs nothing to sit tall. Your back and your brain may both thank you. |
| McGill University · 2026 |
|
|
| The Brain Cells Behind Your Drive |
| Motivation has an address. Researchers at Nagoya University found that a small group of brain cells — orexin neurons, the same ones that keep you awake and alert — fire up when a reward is coming and keep you pushing toward it. Switch them off in rats, and the drive to work for that reward faded. In plain terms, the get-up-and-go you feel is real brain machinery — and it runs best on solid sleep and daylight. |
| PNAS · Nagoya University · 2026 |
|
|
|
|
| |
| Not every hopeful drug is brand new. Some of 2026’s most interesting trials are testing old, cheap medicines and aiming at targets beyond amyloid, the protein that has soaked up most of the attention. Here are three worth watching. |
|
| An Old Diabetes Pill, Tested To Guard Memory |
| Metformin has been around for decades. It is cheap, generic, and taken by millions to steady blood sugar. People with diabetes who take it seem to develop dementia at lower rates — so scientists are asking whether it protects the brain directly. A prevention trial called MAP (Metformin in Alzheimer’s dementia Prevention) is testing exactly that in older adults with early memory changes. The evidence so far is mixed, and this is no reason to start metformin on your own. But a safe, familiar pill that also shields the brain would be a rare bargain. |
| Repurposed drug · prevention trial underway |
|
|
| A Pill Aimed At The Tangles Inside Neurons |
| In Alzheimer’s, a protein called tau twists into tangles that choke brain cells from the inside — like wiring shorting out. Most approved drugs go after amyloid instead. TauRx is taking the other road with an oral pill, hydromethylthionine, built to stop tau from clumping. In its Phase 3 trial, named LUCIDITY, two years on the drug tracked with steadier thinking, and the company has now filed for approval in the United Kingdom. |
| TauRx · Phase 3 (LUCIDITY) · UK filing submitted |
|
|
| A Peptide That Protects The Cell’s Power Plants |
| Brain cells run on tiny power plants called mitochondria. Under the stress of Alzheimer’s, those plants falter and inflammation climbs. GemVax’s GV1001 is a small lab-made peptide — a snippet of the telomerase enzyme — meant to calm that inflammation and keep the power on. In a Phase 2 trial in moderate-to-severe Alzheimer’s, a stage with few good options, it tracked with slower decline. The company is now seeking to test it in the United States. |
| GemVax · Phase 2 · U.S. trial planned |
|
|
